Joao Teixeira, MD
Internal Medicine · Albuquerque, NMNPI 1861658411
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), education and speaking fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Outset Medical Inc at 57.6% of the total. 2025 is the largest year on record at $7,714, more than ten times the $20 reported in 2019. Among internal medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $959.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Outset Medical Inc$11K
- Vantive US Healthcare LLC$6K
- Mallinckrodt Hospital Products Inc.$2K
- La Jolla Pharmaceutical Company$87
- Edwards Lifesciences$20
Across 21 payments — averaging $11,477 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$154K
- Astute Medical, Inc.$77K
- Pfizer$8K
- La Jolla Pharmaceutical Company$2K
What the payments were for
- Consulting fees$8,51547%
- Speaking & faculty fees$3,50319%
- Travel & lodging$8685%
- Food & beverage$5513%
- Education$4,80026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Outset Medical Inc | 4 | $10,503 |
| Vantive US Healthcare LLC | 11 | $6,109 |
| Mallinckrodt Hospital Products Inc. | 2 | $1,518 |
| La Jolla Pharmaceutical Company | 1 | $87 |
| Edwards Lifesciences | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Acute$5,765
- TERLIVAZ$1,515
How this compares
$18,237 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 11 | $74 |
| Amlodipine Besylate | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Albuquerque
- Edward LewieckiAlbuquerque$491K
- James AdairAlbuquerque$108K
- Gulshan ParasherAlbuquerque$66K
- Mark WalkerAlbuquerque$24K
- Karla AlmarazAlbuquerque$18K
- David SosaAlbuquerque$11K
- Revati ReddyAlbuquerque$7K
- Ross DavidsonAlbuquerque$7K
- Edmee RodriguezAlbuquerque$6K
- Anthony ChuangAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.